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 Implication for health policy/practice/research/medical education:
The study discusses strict post HBV vaccination testing to document immunity as a key practice to detect non-responders among 
medical staﬀ and points at the possible consequences of the lack of such a policy. Issues discussed in this article can be useful for those 
at risk of occupational HBV infection, specialists in the ﬁeld of occupational medicine, infectious diseases and health policy makers.
Background: Hepatitis B vaccination, recommended for medical staﬀ, has a non-re-
sponse rate of 5% to 32%. In Poland, there is no standardized postvaccination protocol to 
verify immunity. 
Objectives: To determine the fraction of those who have been vaccinated against HBV 
(with a complete course followed/not followed by a booster) but not checked for sero-
logical evidence of hepatitis B immunity and to detect anti-HBs levels in this group by 
anonymous cross-sectional sero-survey. 
Patients and Methods: Surgical/gynecological staﬀ from 16 randomly selected hospitals 
in West Pomerania, Poland, were surveyed between July 2010-January 2011. EIA system 
version 3.0 was used to detect anti-HBs. 
Results: Of 488 participants (439 females, median age 42 years) who were previously vac-
cinated (1-21 years ago), anti-HBs status was not determined after HBV vaccination in 361 
individuals (74.0%; 95% CI: 69.9-77.7%), 5% (18/361) of whom had an anti-HBs titer of 0.0 
mIU/ml (12/18 who were given booster doses developed anti-HBs > 10 mIU/ml) and 7.2% 
(26/361) of whom had an anti-HBs titer of 0.1-10 mIU/ml. The multivariate logistic regres-
sion model revealed that working in a teaching hospital was associated with lower odds 
of not being checked for anti-HBs after HBV vaccination (OR 0.22, 95% CI: 0.14-0.35; P = 
0.0001). 
Conclusions: The lack of a strict post-HBV vaccination policy to conﬁrm immunity re-
sults in the majority of surgical/gynecological staﬀ not checking their anti-HBs levels 
after HBV immunization. It is unknown whether the absence of current serological 
evidence of hepatitis B immunity can be attributed to non-response, the waning of 
vaccine-induced immunity, or preserved anamnestic response. The lack of a booster vac-
cination response in a fraction of subjects suggests that they are non-responders. Strict 
post-vaccination testing to document immunity remains the key practice to detect non-
responders among medical staﬀ. Copyright  c 2012 Kowsar Corp. All rights reserved.
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1. Background
Due to the frequent involvement in invasive proce-
dures, surgical and gynecological staﬀ are at a higher 
risk of acquiring a blood-borne infection through occu-
pational exposure to blood while carrying out duties re-
lated to patient care (1). The risk of occupational hepati-
tis B virus (HBV) infection is 3-5 times greater than for the 
general population and increases with age and length 186 Hepat Mon. 2012
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of employment (1-3). The sero-prevalence of anti-HBc 
among surgical staﬀ in Poland varies from 16% among 
nurses in various surgical and gynecological wards to 
40% among those working in orthopedic departments 
(3-5). A prevalence of anti-HBc of 13-18% has been reported 
among surgical staﬀ elsewhere (6-8). Because the risk is 
thought to be higher in relation to the general popula-
tion (1, 3), HBV vaccination is strongly recommended for 
those working in the health care sector. A routine vac-
cination policy began in Poland in 1989, with hospitals 
responsible for the cost of vaccinating employees (3). The 
most recent survey of surgical nurses and midwives, con-
ducted in 2009, revealed 100% vaccination coverage (3). 
The implementation of a mass immunization program of 
health care workers (HCWs) has decreased the incidence 
of HBV dramatically (5, 9). A response to HBV vaccination 
is determined by the development of hepatitis B virus 
surface antigen antibodies (anti-HBs), which are detect-
able in 68-95% of individuals 1-2 months after a complete 
vaccination schedule (10-12). The response should be con-
trolled in high-risk individuals, such as medical staﬀ, es-
pecially surgical staﬀ, because those who are involved in 
invasive prone procedures may be at risk of not only ac-
quiring infection but also transmitting HBV to patients 
(1, 5). Those who develop a protective antibody response 
are protected from infection (1, 13). De Shriver et al. (14) 
reported an overview of the diﬀerent policies regard-
ing post-HBV vaccination anti-HBs testing among HCWs 
from 17 European countries, mainly member-states of 
the European Union (EU). Poland, with the Czech Repub-
lic and Denmark, is in a small group of countries where 
there are no strict post-vaccination policies to conﬁrm, 
monitor, or maintain immunity. Various Polish health 
care authorities have published recommendations stat-
ing that “provider units should aim to check the immu-
nity of all HCWs” (15, 16). However, health care facilities 
may vary with regard to the diligence with which they 
attempt to comply with the recommendations. In Po-
land, there is no nationally collected data available to 
assess the success of the initiative. As a result, we do not 
know how medical staﬀ follow the recommendations for 
checking anti-HBs levels after HBV immunization or who 
the interventions should target to promote it. 
2. Objectives
The objective of the survey was to determine the per-
centage of surgical/gynecological staﬀ members who 
were previously vaccinated but not checked for serologi-
cal evidence of hepatitis B immunity and to detect anti-
HBs levels in this group by an anonymous cross-sectional 
sero-survey and evaluate the possible eﬀects of the lack 
of post-vaccination anti-HBs testing on the risk of HBV 
infection.
3. Patients and Methods
Design and Setting: a cross-sectional sero-epidemio-
logical study was conducted from July 2010 to January 
2011 of doctors and nurses employed in the surgical/
gynecological wards of 16 randomly selected hospitals 
from the region of Western Pomerania, Poland. Study 
population and sampling: According to a list of hospi-
tals obtained from the local health department, there 
are 32 hospitals in the region of Western Pomerania: 12 
urban and 20 rural. Multistage, stratiﬁed sampling was 
used for this study, with a random selection of 6 urban 
hospitals and 10 rural hospitals. In the next step, a strati-
ﬁed sampling of wards proportionate to the numbers of 
surgical/gynecological wards was selected for each hos-
pital. Unique code numbers were assigned to all subjects 
to preserve conﬁdentiality. Samples were obtained from 
all eligible staﬀ who provided written informed consent 
to participate. Study instrument: A self-administered 
questionnaire included questions on demographics, in-
cluding age, gender, and job category; hospital charac-
teristics (type of ward, type of hospital); past history of 
conﬁrmed HBV immunization (with/without checking 
for anti-HBs); and receipt of a booster dose. Enzyme im-
munosorbent assay (EIA) system version 3.0 was used to 
detect anti-HBs (Abbott Laboratories Inc., Abbott Park, 
Il, USA). Testing was performed in the referential labora-
tory of a teaching hospital. Vaccinees were considered 
seroprotected when their anti-HBs titer was > 10 mIU/ml 
(12, 16). The antibody titers after vaccination were classi-
ﬁed into 4 groups: ≤ 10 mIU/ml (non-responders), 10.1-
99 mIU/ml (low responders), 100-999 mIU/ml (medium 
responders), and ≥ 1000 mIU/ml (high responders) (10). 
Statistical analysis: Data were entered and validated us-
ing STATISTICA PL Version 7.1. (StatSoft Inc., 2005). Our 
primary outcome variable was a lack of anti-HBs check-
ing after HBV vaccination, and we aimed to identify staﬀ 
characteristics that were associated with this outcome. 
Our secondary outcome variable was anti-HBs level. In 
the univariate analysis, categorical variable groups were 
compared by chi-square test with Yates’ correction and 
Fisher’s exact test, and Mann-Whitney U test was used for 
numerical variables. When more than 2 hypotheses were 
tested, Bonferroni’s correction for multiple comparisons 
was used (adjusted for the number of hypotheses). All 
signiﬁcant variables (P < 0.05) in the univariate analy-
ses were entered into the logistic regression model with 
R software (17). Age, gender, job category (nurse/mid-
wife/doctor), type of ward (surgical/gynecological), and 
type of hospital (teaching/ municipal/provincial) were 
taken into account as potential predictors of not being 
checked for serological evidence of immunity after HBV 
vaccination.
4. Results
Of the 590 eligible personnel, 488 individuals (82.7%) 
agreed to participate, 439 (90%) of whom were female. 
The median age was 42 years (range: 21-60 years). There 
were 424 nurses (86.7%) and 65 doctors (13.3%)—245 
(50.2%) of them worked at surgical wards, 93 (9.1%) at gy-
necological wards, 109 (22.3%) in operating theaters, and 
41 (8.4%) in the admissions area; 282 (57.9%) worked at 187 Hepat Mon. 2012
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urban hospitals (39.1% at teaching hospitals, 18.6% at mu-
nicipal), and 206 (42.1%) at provincial hospitals. 
4.1. HBV Vaccination 
Among 488 subjects who agreed to participate in the 
study, 22 (4.5%) were vaccinated with only 2 doses of HBV 
vaccine, and 191 (39.1%) received 3 doses; 275 (56.4%) com-
pleted the vaccination schedule and were given a booster 
dose. All were vaccinated with yeast-derived recombi-
nant vaccine (Engerix B, SmithKline Beecham Biological, 
Rixensart, Belgium). Of those who were immunized for 
HBV (time of the last administered dose varied from 1 
to 21 years), 485 were able to give a history of their vac-
cinations: 235 (48.5%) were asked to be vaccinated before 
starting work, 210 (43.3%) took a course while working at 
health care facilities, 14 (2.9%) were vaccinated in child-
hood, 14 (2.9%) were vaccinated before planned surgery, 
and 12 (2.5%) gave other reasons.
4.2. Checking for Anti-HBs After HBV Vaccination 
In 361 (74.0%; 95% CI: 69.9-77.7%) participants, anti-HBs 
levels were not checked after the basic course of HBV vac-
cination (Figure 1). Of the 127 subjects who had titers that 
were previously checked, 120 (94.5%) reported immunity. 
4.2.1. Risk Factors for Not Being Checked for Anti-HBs Af-
ter HBV Vaccination 
No statistically signiﬁcant diﬀerences were observed 
in the rates of not being checked for anti-HBs after HBV 
vaccination between gender (P = 0.79), job category (P 
= 0.44), and type of ward (P = 0.26). The lowest rate of 
those who were not checked occurred in those < 30 years 
(23/40; 57.5% were not checked), diﬀering signiﬁcantly (P 
= 0.04) compared to the rates in those aged 31-40 years 
(121/163; 74.2%), 41-50 years (144/188; 76.6%, P = 0.01), and 
> 50 years (73/97; 75.3%, P = 0.04). In addition, the lowest 
rate of those who were not checked was observed in uni-
versity hospitals (107/191; 56.0%), diﬀering signiﬁcantly (P 
= 0.0001) versus municipal (77/91; 84.6%) and provincial 
hospitals (176/206; 85.4%). Variables that were signiﬁcant 
at the univariate level were then entered into a stepwise 
logistic model, which revealed that working in a teach-
ing hospital was associated with smaller odds of not be-
ing checked for serological evidence of immunity after 
HBV vaccination (OR 0.22, 95% CI: 0.14-0.35; P = 0.0001).
4.3. Prevalence of Anti-HBs 
In those whose anti-HBs status was not determined 
after the basic course of HBV vaccination, 317/361 (87.2%) 
subjects (Figure 1) were found to have a recent level of 
anti-HBs > 10 mIU/ ml; in 44/361 (12.2%) subjects, the re-
cent level of anti-HBs was 0-10 mIU/ml (among them, 
18/361 [5.0%] had a recent level of anti-HBs 0.0 mIU/ml). 
All potential non-responders from the group with the 
recent level of anti-HBs 0-10 mIU/ml were asked to immu-
nize themselves with a booster dose of HBV vaccine and 
to check anti-HBs levels 1-2 months later. Although the 
entire group completed the booster, only participants 
from the sub-group with an anti-HBs level of 0.0 mIU/ml 
agreed to check their antibody levels later; 12 of 18 devel-
oped anti-HBs > 10 mIU/ml. Of the 26 participants with a 
recent level of anti-HBs of 0-10 mIU/ml who did not check 
their antibody level after taking the booster, 22 belonged 
to a group that was previously vaccinated with only 2 
doses of HBV vaccine.
5. Discussion
Anti-HBs is an important serological marker for vac-
cine-induced immunity to HBV. Therefore, the practice 
of serotesting after HBV vaccination is widespread. Rec-
ommendations for post-HBV immunization serology for 
persons who are at increased risk of infection exist in 
many countries, such as the US, Canada, Australia, and In-
dia (18). Under EU legislation, employers are responsible 
for protecting their HCWs against blood-borne infections 
(19). The practice of serotesting after HBV vaccination is 
applied in the vast majority of European countries, not 
only for doctors and nurses but also paramedical, tech-
nical, and cleaning staﬀ (14). Data from a large tertiary 
referral teaching hospital in Dublin, Ireland, revealed 
that 93% of nurses reported that hepatitis B antibody 
levels were checked on completion of the immunization 
(20). In a cross-sectional survey that was conducted in 
a teaching hospital in Paris, France, among various job 
categories, the HBV vaccination rate was 93%, with 65% of 
respondents being aware of their immune status (21). As 
discussed, Poland, Denmark, and the Czech Republic are 
the only respondent countries in the European survey of 
hepatitis B vaccination polices that do not perform sero-
Figure 1. The Scheme of Anti-HBs Status After the Basic Course of HBV 
Vaccination and the Recent Level of Anti-HBs Among Surgical and Gyne-
cological Staﬀ188 Hepat Mon. 2012
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logical testing (14). The lack of strict post-HBV vaccina-
tion policy to conﬁrm immunity has resulted in the ma-
jority of Polish surgical/gynecological staﬀ not checking 
their anti-HBs titers after HBV immunization. Because 
the situation in Poland is diﬀerent than in other EU coun-
tries, the reasons for not performing serological testing 
should be considered. Given the current ﬁnancial condi-
tion of health care in Poland, the main issue regarding 
anti-HBs sero-testing after HBV immunization of HCWs 
is who is going to pay for it. Although anti-HBs testing is 
relatively cheap, some health care facilities cannot aﬀord 
it; thus, the responsibility might fall on the medical staﬀ 
to cover the cost. However, if the staﬀ covers the cost, 
they should be informed of the test’s real beneﬁts and 
that it is aimed to simply enhance safety while detecting 
those who are not aware that they are non-responders. 
For individuals and policymakers, the balance between 
health and economic concerns is a critical factor regard-
ing post-HBV vaccination testing. Vaccinated medical 
staﬀ should be aware of their post-vaccination anti-HBs 
status, since they may be one of the 5% to 32% of vaccinees 
who are non-responders and who remain susceptible to 
HBV infection (10-12, 15, 16). Our study shows that the ma-
jority of surgical/gynecological staﬀ does not routinely 
check their post-vaccination titers and that 12% of them 
do not have protective serum anti-HBs concentrations 
(5% has undetectable titers). It is uncertain whether to 
attribute the absence of current serological evidence of 
hepatitis B immunity to nonresponse, waning vaccine-
induced immunity, or preserved anamnestic response 
(22). The lack of a booster vaccination response in one-
third of subjects of those in whom recent anti-HBs levels 
were 0.0 mIU/ml and who had agreed to check their im-
munity after a booster dose suggests that they are non-
responders. Unfortunately, we were unable to obtain 
feedback from participants in whom anti-HBs levels, de-
tected recently in our survey, were 0.1-10 mIU/ml and who 
were asked to immunize themselves with a booster dose 
of HBV vaccine and check anti-HBs level 1-2 months later 
(Figure 1). The vast majority of those with anti-HBs levels 
at 0.1-10 mIU/ml belonged to the group that was vacci-
nated with only 2 doses of HBV vaccine. It is possible that 
participants were convinced that the protective eﬀect of 
a booster dose, even administered years after the second 
vaccine dose, is identical to that of a third dose taken dur-
ing a basic course of HBV vaccination. Clearly, their post-
vaccination anti-HBs status should still be checked.
The study revealed that working in a teaching hospi-
tal is associated with lower odds of not being checked 
for serological evidence of immunity after HBV vacci-
nation. The possible explanation of this ﬁnding is that 
medical personnel who work at academic hospitals have 
more opportunities to gain adequate knowledge about 
the beneﬁts of checking their anti-HBs titers after a ba-
sic course of HBV immunization—eg, by participating 
in various courses, workshops, and conferences on this 
subject. Although it was not assessed in this survey, bet-
ter knowledge on infection control issues by those work-
ing in teaching hospitals was observed among study 
participants (Ganczak, unpublished data). The lack of 
information regarding their initial response to vaccina-
tion may render HCWs at risk of HBV infection. Since a 
small fraction does not exhibit protective anti-HBs titers 
and because post-vaccination anti-HBs testing is not per-
formed to deﬁne non-responders, there may be a sub-
stantial population of surgical/gynecological staﬀ who 
are at risk of contracting HBV infection but are unaware 
of their serological status. An HBV immunization certiﬁ-
cate can oﬀer doctors and nurses a false sense of security, 
leading some to mistakenly think that HBV vaccination 
equals protection, and they also may not report occupa-
tional exposures to HBV from infected patients. The risk 
for contracting HBV within a hospital setting remains 
signiﬁcant. As illustrated in our previous study, expo-
sure to sharps is common in Polish surgical/gynecologi-
cal wards: an average surgeon sustains 10 percutaneous 
injuries per year, and 1 in 2 nurses is exposed to sharps 
injuries every 12 months (23). Only 5% of surgical staﬀ use 
all protective barriers (ie, gloves, masks, eye protection, 
and gowns) regularly. One in 50 occupational exposures 
is reported by surgeons versus 1 in 4 by surgical nurses 
(23). In addition, the HBsAg prevalence among surgical/
gynecological patients is 0.9% (24). 
5.1. Limitations
Potential limitations of this study include it being con-
ﬁned to HCWs in hospitals from the West Pomeranian re-
gion, and it may not be possible to generalize the results 
for all Polish hospitals. Another limitation was its reli-
ance on self-administered questionnaires, which raises 
the issue of the reliability of the gathered data. Participa-
tion bias is also possible, as the majority of participants 
was female. 
5.2. Conclusions and Recommendations
Strict HBV post-vaccination testing to document immu-
nity is critical to detect non-responders among surgical 
staﬀ who are constantly exposed to blood and remains 
the crucial means of decreasing the number of HBV-sus-
ceptible individuals (14, 15, 22). Therefore, it must be in-
corporated into a vaccination program on a mandatory 
basis. To reach greater eﬃciency in post-vaccination anti-
HBs testing coverage among Polish HCWs and among 
other HCWs, greater energy should be spent on lobbying 
for the creation of relevant legislation acts. Until then, 
providing doctors who specialize in occupational health 
with complete information on the risk of hepatitis B 
and on the beneﬁts of post-HBV vaccination testing to 
document immunity of HCWs remains an urgent neces-
sity. Prevention program planners should also focus on 
raising HCW awareness of the issue. However, everyday 
practice shows that safety warnings could be repeated 
forever, but what makes the diﬀerence is well-enforced 
regulation. Targeting all groups of HCWs with appropri-
ate education on HBV infection and active involvement 189 Hepat Mon. 2012
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of professional groups in the planning and execution of 
the vaccination program and the practice of sero-testing 
after HBV vaccination are some of the key points to note 
for future health campaigns. 
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